Go Pro

Akebia Therapeutics (AKBA) Institutional Ownership

Akebia Therapeutics logo
$1.14 +0.03 (+2.70%)
Closing price 06/30/2026 04:00 PM Eastern
Extended Trading
$1.14 0.00 (0.00%)
As of 06/30/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Akebia Therapeutics (NASDAQ:AKBA)

Current
Institutional Ownership
Percentage
33.92%
Number of
Institutional Buyers
(last 12 months)
105
Total
Institutional Inflows
(last 12 months)
$105.41M
Number of
Institutional Sellers
(last 12 months)
33
Total
Institutional Outflows
(last 12 months)
$25.56M
Get AKBA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akebia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AKBA Institutional Buying and Selling by Quarter

Akebia Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE2,763,362$3.84M0.0%+22.4%1.030%
5/16/2026The Manufacturers Life Insurance Company 68,973$96K0.0%-42.7%0.026%
5/14/2026Renaissance Technologies LLC1,833,128$2.55M0.0%-49.0%0.683%
5/7/2026Dimensional Fund Advisors LP921,923$1.28M0.0%-41.3%0.344%
5/5/2026Bank of New York Mellon Corp650,851$905K0.0%-2.4%0.243%
4/30/2026Hsbc Holdings PLC148,092$206K0.0%N/A0.055%
4/27/2026Y Intercept Hong Kong Ltd42,434$59K0.0%N/A0.016%
4/16/2026SG Americas Securities LLC73,069$102K0.0%-57.9%0.027%
3/3/2026Caitong International Asset Management Co. Ltd20,622$33K0.0%+697.8%0.008%
2/23/2026Virtu Financial LLC46,794$75K0.0%N/A0.018%
2/19/2026Invesco Ltd.669,190$1.08M0.0%-72.1%0.252%
2/18/2026XTX Topco Ltd472,485$761K0.0%+1,136.8%0.178%
2/18/2026Wellington Management Group LLP786,465$1.27M0.0%-9.6%0.296%
2/18/2026Polymer Capital Management US LLC72,817$117K0.0%+299.4%0.027%
2/18/2026Oxford Asset Management LLP100,047$161K0.1%N/A0.038%
2/18/2026Millennium Management LLC1,653,469$2.66M0.0%-42.1%0.623%
2/18/2026Man Group plc208,595$336K0.0%+67.6%0.079%
2/18/2026Janus Henderson Group PLC704,020$1.13M0.0%+510.7%0.265%
2/18/2026Caption Management LLC24,692$40K0.0%N/A0.009%
2/17/2026AQR Capital Management LLC646,679$1.04M0.0%+46.2%0.244%
2/17/2026Lazard Asset Management LLC94,563$152K0.0%+275.6%0.036%
2/17/2026Price T Rowe Associates Inc. MD212,680$343K0.0%+4.7%0.080%
2/17/2026Russell Investments Group Ltd.193,737$312K0.0%+46.3%0.073%
2/17/2026Graham Capital Management L.P.376,564$606K0.0%+63.7%0.142%
2/16/2026Squarepoint Ops LLC1,223,027$1.97M0.0%+57.1%0.461%
2/16/2026Barclays PLC923,507$1.49M0.0%-21.8%0.348%
2/13/2026Rafferty Asset Management LLC498,623$803K0.0%+3.5%0.188%
2/13/2026First Trust Advisors LP941,657$1.52M0.0%N/A0.355%
2/13/2026Charles Schwab Investment Management Inc.2,180,820$3.51M0.0%+0.5%0.822%
2/13/2026State Street Corp13,687,561$22.04M0.0%+15.6%5.158%
2/13/2026Wells Fargo & Company MN285,765$460K0.0%+50.3%0.108%
2/12/2026HRT Financial LP1,619,336$2.61M0.0%+6,430.4%0.610%
2/12/2026MetLife Investment Management LLC125,481$202K0.0%-7.2%0.047%
2/12/2026Cibc World Markets Corp16,752$27K0.0%N/A0.006%
2/12/2026Commonwealth Equity Services LLC15,724$25K0.0%-33.7%0.006%
2/12/2026Renaissance Technologies LLC3,593,133$5.79M0.0%-9.1%1.354%
2/12/2026Dimensional Fund Advisors LP1,571,012$2.53M0.0%-11.1%0.592%
2/12/2026EntryPoint Capital LLC127,501$205K0.1%+186.8%0.048%
2/12/2026Federated Hermes Inc.1,291,172$2.08M0.0%+101.9%0.487%
2/12/2026Alps Advisors Inc.217,891$351K0.0%+72.8%0.082%
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

2/12/2026Swiss National Bank496,700$800K0.0%-2.5%0.187%
2/12/2026Nuveen LLC592,991$955K0.0%-74.2%0.223%
2/11/2026Deutsche Bank AG164,655$265K0.0%+5.2%0.062%
2/11/2026LPL Financial LLC61,203$99K0.0%+23.0%0.023%
2/11/2026Franklin Resources Inc.181,619$292K0.0%-93.2%0.068%
2/11/2026WINTON GROUP Ltd65,183$105K0.0%N/A0.025%
2/10/2026Goldman Sachs Group Inc.4,706,437$7.58M0.0%+166.2%1.774%
2/10/2026Northwestern Mutual Wealth Management Co.299,771$483K0.0%+39,976.3%0.113%
2/9/2026Geode Capital Management LLC6,277,177$10.11M0.0%+1.5%2.365%
2/6/2026Empirical Asset Management LLC35,000$56K0.0%+75.0%0.013%
2/6/2026HighTower Advisors LLC27,250$44K0.0%-76.7%0.010%
2/4/2026VIRGINIA RETIREMENT SYSTEMS ET Al85,000$137K0.0%N/A0.032%
1/28/2026Arizona State Retirement System68,845$111K0.0%-11.1%0.026%
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH35,107$57K0.0%N/A0.013%
1/27/2026Round Rock Advisors LLC166,089$267K0.0%+15.9%0.063%
1/23/2026State of Alaska Department of Revenue146,078$235K0.0%+834.9%0.055%
1/14/2026Hennion & Walsh Asset Management Inc.498,961$803K0.0%N/A0.188%
1/9/2026SG Americas Securities LLC173,501$279K0.0%+49.1%0.065%
1/9/2026Assenagon Asset Management S.A.24,872$40K0.0%-94.2%0.009%
1/8/2026Nordea Investment Management AB752,106$1.22M0.0%N/A0.283%
1/1/2026JPMorgan Chase & Co.994,181$2.71M0.0%-39.8%0.375%
11/21/2025CIBC Bancorp USA Inc.26,650$73K0.0%N/A0.010%
11/17/2025Jacobs Levy Equity Management Inc.662,530$1.81M0.0%-45.0%0.250%
11/17/2025CANADA LIFE ASSURANCE Co29,089$79K0.0%N/A0.011%
11/17/2025Voleon Capital Management LP211,766$578K0.0%N/A0.080%
11/17/2025Sherbrooke Park Advisers LLC28,387$77K0.0%N/A0.011%
11/17/2025Polymer Capital Management US LLC18,232$50K0.0%+49.5%0.007%
11/17/2025Qube Research & Technologies Ltd3,206,184$8.75M0.0%+87.0%1.208%
11/17/2025Prelude Capital Management LLC32,840$90K0.0%-21.3%0.012%
11/17/2025Millennium Management LLC2,857,237$7.80M0.0%+32.1%1.077%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.139,736$381K0.0%-6.5%0.053%
11/17/2025Focus Partners Wealth30,591$87K0.0%+130.6%0.012%
11/17/2025Brevan Howard Capital Management LP78,121$213K0.0%+355.6%0.029%
11/17/2025Bank of America Corp DE1,788,500$4.88M0.0%+61.1%0.674%
11/17/2025Aquatic Capital Management LLC506,909$1.38M0.0%+942.3%0.191%
11/17/2025Ameriprise Financial Inc.10,576$29K0.0%-94.0%0.004%
11/14/2025Lazard Asset Management LLC25,174$69K0.0%-78.4%0.009%
11/14/2025Raymond James Financial Inc.69,785$191K0.0%+17.3%0.026%
11/14/2025Freestone Grove Partners LP202,122$552K0.0%N/A0.076%
11/14/2025Man Group plc124,426$340K0.0%+198.3%0.047%
11/14/2025California State Teachers Retirement System247,700$676K0.0%+1,543.3%0.093%
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 55,473$151K0.0%N/A0.021%
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC326,959$893K0.0%+1,097.4%0.123%
11/14/2025Squarepoint Ops LLC778,529$2.13M0.0%+383.0%0.294%
11/13/2025Invesco Ltd.2,400,757$6.55M0.0%+528.1%0.905%
11/13/2025Sei Investments Co.56,500$154K0.0%-70.5%0.021%
11/13/2025UBS Group AG3,646,233$9.95M0.0%+470.2%1.375%
11/13/2025BNP Paribas Financial Markets858,541$2.34M0.0%+64.9%0.324%
11/13/2025Mackenzie Financial Corp265,280$724K0.0%+6.7%0.100%
11/13/2025Franklin Resources Inc.2,680,188$7.32M0.0%+0.5%1.011%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
11/13/2025Legal & General Group Plc245,251$670K0.0%+953.5%0.092%
11/13/2025Russell Investments Group Ltd.132,436$362K0.0%+34.0%0.050%
11/12/2025Barclays PLC1,180,233$3.22M0.0%+19.9%0.445%
11/12/2025Dimensional Fund Advisors LP1,766,691$4.82M0.0%+100.3%0.666%
11/12/2025Victory Capital Management Inc.286,385$782K0.0%+853.6%0.108%
11/12/2025Rafferty Asset Management LLC481,869$1.32M0.0%+89.7%0.182%
11/12/2025Intech Investment Management LLC101,969$278K0.0%-28.7%0.038%
11/12/2025Empirical Asset Management LLC20,000$55K0.0%N/A0.008%
11/10/2025Citigroup Inc.1,916,692$5.23M0.0%+1,324.7%0.723%
11/7/2025GSA Capital Partners LLP182,443$498K0.0%N/A0.069%


AKBA Institutional Ownership - Frequently Asked Questions

During the previous two years, 146 institutional investors and hedge funds held shares of Akebia Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($42.45M), State Street Corp ($22.04M), MPM Bioimpact LLC ($10.52M), Geode Capital Management LLC ($10.11M), UBS Group AG ($9.95M), Qube Research & Technologies Ltd ($8.75M), and Goldman Sachs Group Inc. ($7.58M).Learn more on Akebia Therapeutics' institutional investors.

33.92% of Akebia Therapeutics' stock is owned by institutional investors. Learn more on AKBA's institutional investor holdings.

Of the 134 institutional investors that purchased Akebia Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Goldman Sachs Group Inc. ($6.38M), Vanguard Group Inc. ($3.55M), UBS Group AG ($3.01M), AIGH Capital Management LLC ($2.93M), MPM Bioimpact LLC ($2.89M), State Street Corp ($2.53M), and Woodline Partners LP ($2.49M).

Institutional investors have bought a total of 40,527,033 shares in the last 24 months. This purchase volume represents approximately $105.41M in transactions.

Of the 33 institutional investors that sold Akebia Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Franklin Resources Inc. ($2.50M), Renaissance Technologies LLC ($2.12M), Invesco Ltd. ($1.73M), Nuveen LLC ($1.71M), JPMorgan Chase & Co. ($1.32M), Millennium Management LLC ($1.20M), and Dimensional Fund Advisors LP ($844.77K).

Institutional investors have sold a total of 13,988,000 shares in the last 24 months. This volume of shares sold represents approximately $25.56M in transactions.



This page (NASDAQ:AKBA) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners